metastatic malignant solid tumor Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

M.D. Anderson Cancer Center (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadCHEK2

I am/have/hadovarian failure

I am/have/hadFANCF

I am/have/hadprostate cancer

I am/have/hadBRIP1

I am/have/hadcancer therapy

I am/have/hadneutrophil count

I am/have/hadFANCM

I am/have/hadFANCE

I am/have/hadtumor cells

I am/have/hadhysterectomy

I am/have/hadBARD1

I am/have/hadmetastatic cancer

I am/have/hadrefractory malignant solid neoplasm

I am/have/hadmeasurable disease

I am/have/hadinfertility

I am/have/hadMSH2

I am/have/hadcancer

I am/have/hadabsolute neutrophil count

I am/have/hadfancc

added new label for I am/have/had

more

I am looking for

I am looking forimmune checkpoint inhibitor

I am looking forbap1

I am looking forestrogen

I am looking forprophylactic

I am looking forberzosertib

I am looking forpalb2

I am looking formonoclonal protein

I am looking forprogestin

I am looking forbaf250a

I am looking formonoclonal antibodies

I am looking foravelumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

This phase I/II trial studies the side effects and best dose of avelumab with M6620 in treating patients with deoxyribonucleic acid (DNA) damage repair (DDR) deficient solid tumors that have spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable). DDR deficiency refers to a …

immune checkpoint inhibitor

CHEK2

ovarian failure

prostate cancer

FANCF

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.